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Objective: To study different factors that are associated with fatal sleepiness-related motor vehicle ac-
cidents (FSMVA) and in other types of fatal motor vehicle accidents (FMVA) in Finland.
Methods: All FMVA that were caused by falling asleep at the wheel (FSMVA) during the years 2005e2014
were investigated using OTI (Finnish Crash Data Institute) data. The control group consisted of 136
drivers who died in other types of FMVA in 2013. A total of 258 accidents were investigated.
Results: The mean age of the 122 drivers in the FSMVA group was 44 (standard deviation 19) years; there
were 100 men (82%) and 22 women. The mean age of the 136 control drivers was 45 (standard deviation
19) years; there were 116 men (85%) and 20 women. Short sleep time (<6 h) during the previous night
before the accident was the most prominent independent risk factor for FSMVA compared to other FMVA
(p < 0.05). None of the other driver-related factors (diseases, blood alcohol level, illegal drugs, body mass
index, medications, age, sex) differed signiﬁcantly between the two groups.
Conclusion: Short sleep is a major cause of fatal sleepiness-related motor vehicle accidents. Driver health
factors such as sleep apnea or acute/chronic diseases as well as use of sedative medications and drugs are
known risk factors for FSMVA, but these factors are associated also with other types of accidents. Healthy
individuals are at risk for falling asleep while driving if they are sleep deprived. All drivers should be
aware of the importance of adequate sleep.
© 2018 Elsevier B.V. All rights reserved.1. Introduction
Falling asleep at the wheel can cause serious road accidents. In
addition to the driver and passengers, all other road users are in
danger if a driver falls asleep while driving. Based on a national
analysis of fatal motor vehicle accidents from 1991 to 2001, 10% of
accidents of nonprofessional nonintoxicated drivers were caused
by falling asleep while driving [1], and this proportion seems to be
rather stable in recent years based on annual reports of the Finnish
Crash Data Institute (OTI annual report 2013 and 2014). Seasonal
risk factors for accidents involving falling asleep have also been
investigated in Finland. Sleepiness-related accidents are especially
common in younger drivers between May and August [2,3]. Among
military personnel, falling asleep has been the main cause of motor
vehicle accidents; these individuals may be exposed to acute sleep
deprivation during military service. Students may get insufﬁcient70200, Kuopio, Finland.sleep, for example, because of using alcohol or medications to
induce sleep [4]. The prevalence of short sleep and sleep debt is
highly prevalent in adults aged 25e45 years in France: short sleep,
18%; insomnia, 12%; and sleep debt, 20% [5] The prevalence of
insomnia seems to be 1.5 higher in Finland (37.6%) compared to
other European countries [6]. Individuals in shift work had
insomnia or excessive sleepiness more often than the general
population [7].
Previous studies indicate that obstructive sleep apnea (OSA)
increases the risk of motor vehicle accidents [8], although in
Finland, among truck drivers, OSA did not signiﬁcantly increase the
risk of motor vehicle accidents [9]. Insufﬁcient sleep was reported
to be a more signiﬁcant risk factor in motor vehicle accidents than
the apneahypopnea index [10] Drivers in accidents involving
falling asleepmore often have sleep deprivation than thosewithout
sleep-related problems [11]. Sleepiness is also often related to
medical conditions [12]. In addition to OSA, depression, narcolepsy,
and use of sleeping medication or other drugs affecting the central
nervous system may cause daytime sleepiness. Alcoholism is also
linked to a high prevalence of insomnia [13]. Studies show that use
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Driving under the inﬂuence of drugs and/or medicine is a major
problem in Finland, and drivers using benzodiazepines had a higher
risk of death than drivers using amphetamines [15].
2. Methods
2.1. Ethics and study outline
The study plan was reviewed and approved by the Finnish
Motor Insurer's Centre.
All fatal trafﬁc accidents in Finland have been investigated in
depth since 1967 based on legislation (law 1512/2016) (Finnish
Motor Insurer's Center 2004). Each fatal road and off-road accidents
are investigated by multidisciplinary road accident investigation
teams (RAITs) in Finland. The investigation teams have expert
representation from the police, the ﬁeld of medicine, vehicle
technology, road maintenance, and behavioral sciences. The pur-
pose of investigation is to improve road safety and to ﬁnd the real
causes and risks relating to the accidents. The police investigation
on the criminal or juridical aspects of the accidents is conducted
separately and individually outside the accident investigation
process. In this study, we considered only those accidents with the
key event of falling asleep while driving and in which the driver
was killed during 2005e2014. We excluded from the study those
accidents in which the RAITs had deﬁned fatigue as a background
factor but the key event was not falling asleep at the wheel, so that
we could only include those accidents inwhich the driver had most
certainly fallen asleep. In fatigue-related accidents, there may be
more accidents involving falling asleep than ofﬁcially identiﬁed,
and we did not include these cases in the control group. It is likely
that in some of the accidents inwhich fatigue was considered a risk
factor, falling asleep was the real cause of the accident. The purpose
of the study was not to determine the exact proportion of the ac-
cidents involving falling asleep but rather to investigate this in
another study. Based on a previous study [2], we know the char-
acteristic signs of accidents involving falling asleep; these include
driving off the road from a straight road, in the middle of a curve, or
into the opposite lane; excessive speed and no braking marks;
uncontrolled turns; less than 6 h' sleep the night before the acci-
dent; long driving time (>10 h); driving in the morning atTable 1
Health-related factors associated with fatal road accidents.
Health risk Nonsleep-related accidents
No chronic disease 36.0%
Cardiovascular disease 21.3%
Cerebrovascular disease 2.8%
Diabetes 3.7%
Metabolic disease 5.1%
Neurological disease 5.1%
Dementia 0%
Eye disease 0.7%
Central nervous system disease 0%
Sleep disorder 0%
Psychiatric disorder 17.6%
Substance/alcohol dependence 8.8%
Musculoskeletal disease 5.1%
Disability 0%
Insomnia 0%
Other disease 8.8%
Obesity 15.4%
Daytime fatigue 0%
BAC >0 32.8%
Psychoactive medication 22.1%
Illegal drugs 6.6%
Statistically signiﬁcant differences between the two groups are shown in boldface type.01:00e06:00 or afternoon 14:00e17:00; and awake time of >16 h.
RAITs have been using this information when deciding the key
event of an accident as falling asleep. The control group was FMVA
from the year 2013 in which driver had been killed (excluding
falling asleep, sudden disease attacks, and fatigue-related
accidents).2.2. Statistical analysis
We compared the differences in factors contributing to FSMVA
with those in a control group (CGR). We used multivariate logistic
regression analysis to identify factors exclusively associated with
FSMVA using Stata 14.0 software (StataCorp, College Station, TX,
USA). Data included the driver's age and sex, time of accident, type
of accident and vehicle, driver's medications, blood alcohol con-
centration and drug/medication ﬁndings in the blood, body mass
index (BMI), disease history (Table 1), smoking, use of caffeine,
sleep time preceding the night of the accident, and time awake. We
compared independently the health-related factors for FSMVA and
CGR with the c2 test. The driver's blood sample data (including
alcohol, drugs, and medication use) and driver's height and weight
were collected from the forensic autopsy report. BMIwas calculated
if the height and weight were available in the accident folder.
Health information was collected from accident folders; RAITs are
entitled to use all of the existing health records of the drivers. We
present a few examples in which the driver's health had posed a
background risk for FSMVA. We classiﬁed sleep time in three
classes: <6 h, 6e7.9 h, and 8 h. Drivers were classiﬁed as obese
(BMI 30 kg/m2) or not obese (<30 kg/m2).3. Results
3.1. Demographics
There were 122 drivers (mean age 44 years, standard deviation
[SD] 19 years, 82%men) in the FAA group and 136 drivers (mean age
45 years, SD 19 years, 85% men) in the CGR. The proportions of
young drivers (age <25 years) were almost the same (20.5% in
FSMVA and 23.5% in CGR) (Fig. 1). Senior drivers (age 70 years)
comprised 13.9% of the FMVA group and 13.2% of the CGR.Sleep-related accidents p
34.4% NS
25.4% NS
0.8% NS
4.1% NS
8.2% NS
3.3% NS
0% NS
0% NS
2.5% NS
7.4% <0.05
12.3% NS
9.8% NS
4.1% NS
0% NS
5.7% <0.01
21.3% <0.05
24.6% <0.05
10.1% <0.05
21.7% <0.05
18.9% NS
6.6% NS
BAC, blood alcohol concentration.
Fig. 1. Age group distribution in the control group (CGR) and in the group with motor vehicle accidents involving falling asleep (FSMVA).
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In this studywe used threemodels (Table 2). In model 1 we used
only short sleep as an explanatory variable. In model 2 we used
short sleep, BMI, sex, and age, and in model 3 we added duration of
time awake before accident (TAWBA) and blood alcohol concen-
tration. Based on multivariate logistic regression analysis, only
short sleep time was an independent factor for FSMVA. Seven
drivers in the FSMVA group had a TAWBA of >21 h, and the CGP did
not have any drivers with equal awake time; therefore, statistical
analysis related to TAWBA was not feasible. Model 3 included age,
sex, BMI, and short sleep time (<6 h the preceding night). In this
analysis, sleeping less than 6 h was statistically signiﬁcantly asso-
ciated with FSMVA (odds ratio [OR]¼ 9.45; 95% conﬁdence interval
[CI] ¼ 1.49e59.97). Sleep-related health conditions (sleep disorder,
daytime fatigue, insomnia) could not been analyzed because these
factors were not found in any of the drivers in the CGR. Analyses
show that driver BMI as a continuous or classiﬁed variable was not
associated with accidents involving falling asleep. Five of the seven
heavy vehicle drivers in FSMVA were obese (BMI 30 kg/m2) and
one was overweight (BMI ¼ 27.4 kg/m2). In one case, information
for calculating BMI was not available. Of the drivers in FSMVA, 75%
(n ¼ 92) had health-related background factors and in the CGR 68%
(n ¼ 93) of drivers had at least one health-related background
factor (alcohol or drug use, medical condition, central nervous
system medication, sleep-related disorder). The variable “otherTable 2
Logistic regression models for sleep-related fatal accidents.
Univariate model 1
OR (95% CI)
Sleep <6 h 3.81 (1.22e11.85)
Men vs women
Age
BMI 30 kg/m2
BAC
TAWBA
Statistically signiﬁcant odds ratios are shown in boldface type. BAC, blood alcohol conc
duration of time awake before accident.diseases” is the only variable that differed between FSMVA drivers
and the CGR, according to the c2 test. In addition, this variable was
not signiﬁcant in logistic regression models when short sleep was
included. The “other diseases” variable comprises various medical
conditions such as acute infectious diseases (eg, respiratory in-
fections) and cancers (eg, the case of a young healthy man with
acute mononucleosis falling asleep while driving). Another
example of “other diseases” involved an individual in the ﬁnal stage
of cirrhosis of the liver. The prevalence of obesity was higher in
FSMVA (24.6% vs 15.4%), but obesity is not signiﬁcant in logistic
regressionmodels. Sleeping timewas known in 33.6% of the FSMVA
drivers and in 27.9% of the CRP.3.3. Role of sleep-related health conditions
Sixteen drivers in FSMVA had a diagnosed sleep disorder (sleep
apnea, narcolepsy), daytime fatigue, or insomnia listed as a back-
ground risk, however none of the drivers in the CGP group had any
sleep disorders. Sleep apnea had been diagnosed in three of the
drivers in the FSMVA group, and two of them did not use contin-
uous positive airway pressure (CPAP) although they had a CPAP
device. One driver had experienced excessive daytime sleepiness
with involuntary sleep attacks. The reason for his sleepiness was
unknown. Forensic autopsy data information about neck size and
waist circumference was not available.Model 2
OR (95% CI)
Model 3 (fully adjusted)
OR (95% CI)
4.94 (1.13e21.54) 9.45 (1.49e59.97)
1.21 (0.31e4.74) 1.13 (0.26e4.99)
1.00 (0.97e1.03) 1.00 (0.96e1.03)
1.81 (0.50e6.58) 1.25 (0.31e4.99)
0.46 (0.18e1.19)
1.71 (0.73e4.02)
entration; BMI, body mass index; CI, conﬁdence interval; OR, odds ratio; TAWBA,
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Head-on collisions (51.6% vs 44.1%) and drift-off accidents (46%
vs 32.4%) are more common in FSMVA. Drivers were more likely to
drive a light vehicle (passenger car) in the FSMVA group than in the
CGP (87.7% vs 67.6%). Drivers were driving a heavy vehicle in 5.7% in
the FMVA group and 2.9% in the CGR. All accidents weremost likely
to occur from 12:00 to 17:59 (FSMVA 41% and CGP 42.7%). During
the early morning hours (03:00e05:59), 14.8% of FSMVA occurred
and 7.4% of the CGR. The peaks of FMVA were during 03:00e05:59
and 12:00e17:59. During the summertime (MayeAugust), 49.3% of
accidents occurred in the CGR and 48.4% in the FSMVA group. The
majority of the drivers died on the site of the accident before
receiving ﬁrst aid (FMVA 86.1% vs CGP 81.6%).
3.5. Alcohol/substance use and medications
Of all drivers, 21.7% (26/120, two with missing data) in the
FSMVA group had alcohol in the blood (blood alcohol concentration
>0) vs 32.8% (43/131, ﬁve with missing data) in the CRP (p¼ 0.048).
In all, 18.9% of FSMVA drivers had a medication that could affect
alertness (opioids, antipsychotics, sedatives, antihistamines) and
22.1% in the CGR (p > 0.05). In 6.6% of the drivers in both groups,
individuals were found to be under the inﬂuence of drugs
(amphetamine, cannabis, cocaine, opioids), or drug metabolites
were found in the blood or urine. Caffeine was found in 45.1% of
drivers in the FSMVA group and 40.4% in CGR (no data: 38.5%/
43.4%). The prevalence of smoking or nicotine use was almost the
same (21.3% in the FSMVA group and 19.9% in the CGR).
4. Discussion
Acute sleep insufﬁciency (sleeping <6 h on the previous night)
was the only independent factor identiﬁed in relation to FMVA
drivers compared to the CGR. All the drivers (n ¼ 7) with extended
wakefulness time (>21 h) fell asleep while driving. Our study con-
ﬁrms a previous study ﬁnding that sleep disorders and sleepiness at
the wheel are risk factors for trafﬁc accidents [16]. Based on the
ﬁndings, we can assume that TAWBA is probably a risk factor for
FSMVA even though we were not able to perform a statistical anal-
ysis. Sleep is vital for brain energy levels [17]. A high proportion of all
the drivers in all of the accidents had health-related risk factor(s).
Alcohol and drugs had a major role in both the FSMVA group and
CGR, but substance abuse was not an independent factor related to
FSMVA compared to CGR; alcohol played a larger role as a back-
ground risk factor in the CGR. Only a few of the drivers in the FSMVA
group had sleep-related conditions, and obstructive sleep apnea
(OSA) was diagnosed in only three of these drivers. Based on this
study, OSA is not a signiﬁcant cause of FSMVA. Taking into account
the previous population studies in Finland, it is likely that sleep-
related conditions are underrepresented in this study, based on
the fact that OSA is underdiagnosed in the population. Obesity is a
major risk factor for OSA [18]. The prevalence of obesity was higher
in the FSMVA group, with one of four drivers being obese; however,
the real prevalence is likely higher because in about 30% of the cases
BMI data could not be calculated. Obesity is a known risk for trafﬁc
accidents [19,20]. Obesity is associated, for example, with chronic
inﬂammation [21] and inﬂammatory mediators [22]. Excessive
daytime sleepiness among obese individuals is a complex topic, and
OSA is only one reason for this [23]. Moreover, a high-fat diet, high
sympathetic activity, hormones, and cytokines are associated with
daytime sleepiness [24]. Sleep-related medical conditions were not
found in any of the drivers in the CGR; this is because fatigue-related
accidents were excluded from this study. However, benzodiazepines
were found in the blood of 18 drivers in the CGR, and many of thesedrivers may have had some kind of sleep disorder. If the fatigue-
related accidents had been in the CGR, these variables may had
been statistically signiﬁcant in a logistic regression model. Motor-
cyclists are almost absent from FSMVA. Driving a motorcycle may
require more attention from the driver, and this may have protective
effect on falling asleep. The prevalence of smoking was more or less
the same compared to that of the male adult population in Finland.
The CGR contained road suicides, and among these incidents the use
of alcohol and drugs is common [25]. This may partly explain why
alcohol seems to be amore frequent risk factor in the CGP than in the
FSMVA group. The prevalence of all accidents was higher in sum-
mertime, and also FSMVA occurred more in the summertime; this
phenomenon has also been identiﬁed in a previous study [2].
Pharmacological treatment of insomia in drivers with daytime
sleepiness is somewhat controversial. Benzodiazepines and
benzodiazepine-like Z-drugs (eg, zopiclone and zolpidem) increase
sleep duration [26], but they (especially zopiclone) [27] may also be
associated with an increased risk of trafﬁc accidents [28,29]. Mean
weekly sleep duration among highway drivers has decreased in
France between the years 1996 and 2011 [30], and it seems that
drowsy driving has been an increasing challenge to trafﬁc safety.
An notable ﬁnding was that in all fatal accidents in this study,
the drivers died almost immediately and in any case before the
arrival of an ambulance. At the end of the year 2012, the average age
of the passenger car used in trafﬁc in Finland was 10.9 years (Traﬁ;
Finnish Transport Safety Agency). Newer cars are safer for drivers
than older cars; especially in accidents involving falling asleep,
vehicles with advanced passive features can reduce the conse-
quences of the accident.
The major strength of the present study is the comprehensive
countrywide accident investigation in Finland, which makes it
possible to identify both the immediate and background risks of
FMVA and the circumstances of the accidents with good precision.
Accident investigation includes every FMVA on the road. Health
records and forensic autopsy information allows one a chance to
analyze true health-related risk factors for FMVA. The most
important limitation of the study is the number of accidents
involving falling asleep and the lack of information on sleeping
time preceding the night of the accident in themajority of the cases
(sleeping time was known in 33.6% of FSMVA cases and 27.9% of
CGR). Forensic autopsy data about neck size and waist circumfer-
ence were not available, so the possible prevalence of OSA in ac-
cidents involving falling asleep could not be assessed adequately. In
the present study, the duration (quantity) of sleep was signiﬁcant
factor, but data on sleep depth (ie, quality) was often not available.
The key factor (falling asleep while driving) was determined by
road accident investigation teams. It is possible that some sudden
disease attacks or other fatal accidents actually, however, involve
falling asleep. We excluded from the CGR those accidents with a
background risk of fatigue because it is almost sure that these ac-
cidents include those caused by falling asleep. The purpose was to
exclude the source of error from the CGR.
5. Conclusion
The present study conﬁrms the conception of sleep deprivation
as major cause of fatal automobile accidents and conﬁrms the re-
sults of a previous study in Finland: Partinen suggested in 2004 that
the proportion of sleepiness-related road accidents is between 4.8%
and 30% [2]. The present study conﬁrms that sleep deprivation is an
independent health-related factor in FSMVA compared to the rest
of FMVA. Anyone can fall asleep unintentionally after sleep depri-
vation. Drivers should be more aware of risks to trafﬁc safety
related to sleep deprivation. As a simple general rule, one should
sleep at least 6 h before starting to drive for a long period of time.
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